Altre lingue Applied DNA Sciences, Inc.

Azioni

APDN

US03815U4094

Tempo reale stimato Cboe BZX Altri mercati azionari 20:34:29 21/05/2024			Variaz. 5gg	Var. 1 gen.
1,885 ^USD	-3,83%		-41,93%	-84,84%

14/05	APPLIED DNA SCIENCES, INC. : downgrade a Neutral da Maxim	ZM
13/05	I principali ribassisti del pre-mercato	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement	13/05
Top Premarket Decliners	13/05
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot	10/05
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q2 Revenue $929,631	10/05
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	10/05
Applied DNA Sciences Regains Nasdaq Minimum Bid Price Requirement	10/05
Banned Chinese cotton found in 19% of US retailers' merchandise, study shows	07/05
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program	26/04
Applied DNA Sciences, Inc. Receives Contract by HDT Bio for Rapid Vaccine Development Program	25/04
Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03/04
Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03/04
Certain Common Stock of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03/04
Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress	15/03
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress	14/03
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings	12/03
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot	08/02
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q1 Revenue $891,164	08/02
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	08/02
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	01/02
Applied DNA Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow	15/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Applied DNA Sciences, Inc.

Azioni

APDN

US03815U4094

Altre lingue

Filtri